and Item 1A. Risk Factors of Part I and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations of Part II of this Annual Report on Form 10-K. Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission (the SEC). In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of suc...
Q2 FY2026 — expected 2026-09-07
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-25 | 2025-09-30 | 0000879407-25-000029 | EDGAR | 84K words |
| 2024-11-26 | 2024-09-30 | 0001628280-24-049277 | EDGAR | — |
| 2023-11-29 | 2023-09-30 | 0001628280-23-040219 | EDGAR | — |
| 2022-11-28 | 2022-09-30 | 0001628280-22-030869 | EDGAR | — |
| 2021-11-22 | 2021-09-30 | 0001564590-21-057888 | EDGAR | — |
| 2020-11-23 | 2020-09-30 | 0001564590-20-054893 | EDGAR | — |
| 2019-11-25 | 2019-09-30 | 0001564590-19-044376 | EDGAR | — |
| 2018-12-11 | 2018-09-30 | 0001564590-18-030805 | EDGAR | — |
| 2017-12-12 | 2017-09-30 | 0001564590-17-024834 | EDGAR | — |
| 2016-12-14 | 2016-09-30 | 0001564590-16-030217 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-05 | 2025-12-31 | 0000879407-26-000034 | EDGAR | 90K words |
| 2025-08-07 | 2025-06-30 | 0001628280-25-038858 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001628280-25-024666 | EDGAR | — |
| 2025-02-10 | 2024-12-31 | 0001628280-25-004634 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001628280-24-036104 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001628280-24-022215 | EDGAR | — |
| 2024-02-06 | 2023-12-31 | 0001628280-24-003492 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001628280-23-027771 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0001628280-23-014856 | EDGAR | — |
| 2023-02-06 | 2022-12-31 | 0001628280-23-002413 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001628280-22-021068 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001564590-22-019275 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-20 | 0000879407-26-000037 | EDGAR | 1K words |
| 2026-02-05 | 0000879407-26-000033 | EDGAR | — |
| 2026-01-12 | 0001193125-26-010582 | EDGAR | — |
| 2026-01-09 | 0001193125-26-007971 | EDGAR | — |
| 2026-01-06 | 0000879407-26-000004 | EDGAR | — |
| 2025-11-25 | 0000879407-25-000027 | EDGAR | — |
| 2025-11-18 | 0000879407-25-000019 | EDGAR | — |
| 2025-09-12 | 0000879407-25-000010 | EDGAR | — |
| 2025-09-11 | 0000879407-25-000007 | EDGAR | — |
| 2025-09-02 | 0000879407-25-000004 | EDGAR | — |
297 total filings indexed. 265 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000879407 |
| Ticker | ARWR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.arrowheadpharma.com |
| Listed | 1995-02-01 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report